Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | SLC26A3 | P40879 | 4/20 | 0.48 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.48 |
| ▸ | CA12 | O43570 | 4/20 | 0.47 |
| ▸ | CA9 | Q16790 | 4/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | MTOR | P42345 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7121835 | 0.89 | KDM4E (0.40) | TP53SLC26A3PTGDR2CA12CA9 | |
| SCHEMBL5085076 | 0.84 | TP53 (0.51) | TP53SLC26A3PTGDR2CA12CA9 | |
| SCHEMBL29579782 | 0.79 | PSMB8 (0.45) | TP53SLC26A3PTGDR2CA12CA9 | |
| SCHEMBL307859 | 0.78 | CA12 (0.60) | TP53CA12CA9POLBMEN1 | |
| SCHEMBL30772200 | 0.77 | PTGDR2 (0.46) | TP53SLC26A3PTGDR2CA12CA9 | |
| SCHEMBL17157529 | 0.75 | KMT2A (0.45) | TP53SLC26A3PTGDR2CA12CA9 | |
| SCHEMBL6578104 | 0.75 | CA12 (0.49) | CA12CA9POLBMAPTKDM4E | |
| SCHEMBL29111160 | 0.74 | MAPT (0.50) | TP53SLC26A3PTGDR2CA12CA9 | |
| SCHEMBL29752815 | 0.73 | SRC (0.64) | CA12CA9POLBMEN1NPC1 | |
| SCHEMBL17088977 | 0.73 | KDM4E (0.60) | TP53CA12CA9POLBMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111675761-B | Purpurin-4 binding proteins and methods of use thereof | 艾更斯司股份有限公司 | 2023-10-20 | — | — | CN | disclosed |
| CN-114578038-A | Computer process after AQUA enhanced version | 诺华股份有限公司 | 2022-06-03 | — | — | CN | disclosed |
| WO-2017182580-A1 | METHODS FOR THE DIAGNOSIS AND THE TREATMENT OF REPRODUCTION-RELATED DISORDERS AND METHODS FOR CONTRACEPTION | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2017-10-26 | — | — | WO | disclosed |
| US-8039648-B2 | Compounds used as dyes comperable to Alexa Fluor 350 dyes | PIERCE BIOTECHNOLOGY, INC. (US) | 2011-10-18 | — | — | US | disclosed |
| US-20100317045-A1 | COMPOUNDS USED AS DYES COMPERABLE TO ALEXA FLUOR 350 DYES | PIERCE BIOTECHNOLOGY, INC. (US) | 2010-12-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100317045-A1 | COMPOUNDS USED AS DYES COMPERABLE TO ALEXA FLUOR 350 DYES | ACR, RO60, ARF5 | TP53 181/4885SLC26A3 3421/4885PTGDR2 4518/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.